Scholarly Index
Kristina S. Boye
Eli Lilly (United States); 4,956 total citations; 220 total publications; best world rank #123
Eli Lilly (United States)
4,956Total citations
220Total publications
38H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Management and Research | Lifetime | 790 | US 336 | 97.53 |
| Diabetes Treatment and Management | Lifetime | 810 | US 299 | 97.25 |
| Medication Adherence and Compliance | Lifetime | 300 | US 183 | 95.83 |
| Diabetes Management and Education | Lifetime | 696 | US 319 | 94.22 |
| Pharmacology and Obesity Treatment | Lifetime | 779 | US 337 | 92.47 |
| Diabetes Management and Research | 2021-2025 | 291 | US 132 | 96.40 |
| Diabetes Treatment and Management | 2021-2025 | 398 | US 139 | 95.73 |
| Medication Adherence and Compliance | 2021-2025 | 123 | US 51 | 91.51 |
| Diabetes Management and Education | 2021-2025 | 267 | US 98 | 88.58 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 478 | US 116 | 90.51 |
| Bariatric Surgery and Outcomes | 2021-2025 | 413 | US 118 | 89.83 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 530 | US 141 | 86.55 |
| Obesity and Health Practices | 2021-2025 | 757 | US 319 | 73.19 |
| Pharmacology and Obesity Treatment | 2021-2025 | 756 | US 288 | 64.19 |